TipRanks
Go Ultimate55% OFF

PHC Holdings Corp. (6523) AI Stock Analysis

JP:6523

PHC Holdings Corp.

(TSE/TYO:6523)

Select Model
Rating:60Neutral
Price Target:JPY 1,431.00â–²(1.85% Upside)
Action:reiterated
Date:10/14/26

The overall score is driven primarily by the company's robust cash flow and improving balance sheet, which provide financial stability. However, the score is significantly constrained by extremely weak net profitability and low return on equity. Technicals show a stock consolidating in a longer-term uptrend, while the valuation is fair with a solid dividend yield.

Positive Factors
Strong Cash GenerationPHC generates substantial operating and free cash flow despite thin reported earnings, indicating healthy cash conversion from its healthcare operations. Sustained cash production can support debt service, ongoing investment, and customer support while providing resilience across the next several quarters.
Negative Factors
Near-Breakeven Net ProfitabilityVery thin net profitability shows that PHC is not consistently converting solid gross margins and positive operating earnings into durable bottom-line returns. This limits internal capital formation and leaves earnings more vulnerable to cost, financing, or operating pressures.

PHC Holdings Corp. (6523) vs. iShares MSCI Japan ETF (EWJ)

-20%0%20%40%60%80%JP:6523+44.10%EWJ+17.00%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
JPY 180.17B
Dividend Yield
2.97%
Average Volume (3M)
1.13M
Price to Earnings (P/E)
19.5
Beta (1Y)
0.78
Revenue Growth
3.04%
EPS Growth
-19.26%
Country
Japan
Employees
8,647
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

PHC Holdings Corp. Business Overview & Revenue Model

Company Description

PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blo...

How the Company Makes Money

PHC Holdings primarily makes money by selling healthcare and life-science products and related consumables to hospitals, clinics, laboratories, research institutions, and distributors, generating revenue from both (1) capital equipment sales and (2)...

PHC Holdings Corp. Financial Statement Overview

Summary

Strong cash flow generation (Score 70) and an improving balance sheet (Score 55) are offset by very weak profitability (Score 45). Net margins are razor-thin at 0.14%, and return on equity is low, indicating the company is not efficiently converting revenue into profit despite healthy gross margins.

Income Statement

45Neutral

Balance Sheet

55Neutral

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue371.22B364.40B361.59B353.90B356.43B340.45B
Gross Profit170.27B165.26B166.22B157.97B169.13B165.24B
EBITDA54.54B47.72B52.33B30.15B36.76B37.56B
Net Income9.17B492.00M10.48B-12.89B-3.22B-8.46B
Balance Sheet
Total Assets543.08B542.51B532.48B564.33B561.57B591.32B
Cash, Cash Equivalents and Short-Term Investments41.28B39.82B43.90B51.82B63.25B97.63B
Total Debt229.26B234.56B269.26B300.28B307.24B323.32B
Total Liabilities374.61B381.63B391.31B425.16B422.74B455.25B
Stockholders Equity169.31B161.67B141.64B139.51B138.01B135.37B
Cash Flow
Free Cash Flow41.83B33.37B30.33B26.67B9.86B39.32B
Operating Cash Flow51.41B42.46B41.94B41.30B21.38B51.05B
Investing Cash Flow-9.70B-8.45B-8.47B-23.68B-17.52B-12.52B
Financing Cash Flow-39.29B-39.82B-39.07B-36.53B-40.83B-7.01B

PHC Holdings Corp. Technical Analysis

Technical Analysis SentimentPositive
Last Price1405.00

Price Trends

50DMA1412.84Positive
100DMA1248.93Positive
200DMA1146.40Positive

Market Momentum

MACD-17.43Positive
RSI53.36Neutral
STOCH88.77Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6523, the sentiment is Positive. The current price of 1405.00 is below the 20-day moving average (MA) of 1416.30, below the 50-day MA of 1412.84, and above the 200-day MA of 1146.40, indicating a neutral trend. The MACD of -17.43 indicates Positive momentum. The RSI at 53.36 is Neutral, neither overbought nor oversold. The STOCH value of 88.77 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6523.

PHC Holdings Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:6523 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6678JP:667882OutperformJPY 18.42B12.22―5.97%20.88%44.61%
JP:7963JP:796364NeutralJPY 8.49B10.10―2.90%9.02%8.88%
JP:6849JP:684961NeutralJPY 265.01B19.32―1.98%1.43%1.86%
JP:6523JP:652360NeutralJPY 180.17B19.535.76%2.97%3.04%-19.26%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:4549JP:454950NeutralJPY 76.06B41.05―2.51%3.92%-52.01%
JP:7600JP:760047NeutralJPY 15.22B-69.06―2.94%-6.64%67.08%

* Healthcare Sector Average

Performance Comparison

0%50%100%JP:6523JP:4549JP:6678JP:6849JP:7600JP:7963Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
JP:6523 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:6523PHC Holdings Corp.1415.00422.4342.56%
JP:4549Eiken Chemical Co., Ltd.2307.00-26.34-1.13%
JP:6678Techno Medica Co., Ltd.2161.00334.3718.31%
JP:6849Nihon Kohden Corporation1616.50-130.88-7.49%
JP:7600Japan Medical Dynamic Marketing, Inc.578.0098.5020.54%
JP:7963Koken Ltd.1727.00-96.08-5.27%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 14, 2026